Ausgabe 8/2007
Inhalt (16 Artikel)
Herbert Andre Fleisch, MD
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
J. A. Cramer, D. T. Gold, S. L. Silverman, E. M. Lewiecki
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis, A. Oden, O. Johnell, H. Johansson, C. De Laet, J. Brown, P. Burckhardt, C. Cooper, C. Christiansen, S. Cummings, J. A. Eisman, S. Fujiwara, C. Glüer, D. Goltzman, D. Hans, M.-A. Krieg, A. La Croix, E. McCloskey, D. Mellstrom, L. J. Melton III, H. Pols, J. Reeve, K. Sanders, A-M. Schott, A. Silman, D. Torgerson, T. van Staa, N. B. Watts, N. Yoshimura
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
O. Ström, F. Borgström, S. S. Sen, S. Boonen, P. Haentjens, O. Johnell, J. A. Kanis
Urban-rural differences in distal forearm fractures: Cohort Norway
A. J. Søgaard, T. K. Gustad, E. Bjertness, G. S. Tell, B. Schei, N. Emaus, H. E. Meyer
The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys
M. S. Ominsky, P. J. Kostenuik, P. Cranmer, S. Y. Smith, J. E. Atkinson
Impaired geometric properties of tibia in older women with hip fracture history
T. Mikkola, S. Sipilä, E. Portegijs, M. Kallinen, M. Alén, I. Kiviranta, M. Pekkonen, A. Heinonen
Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis
O. Gajic-Veljanoski, R. J. Sebaldt, A. M. Davis, D. Tritchler, G. Tomlinson, A. Petrie, J. D. Adachi, A. M. Cheung
Modifiable lifestyle factors affecting bone health using calcaneus quantitative ultrasound in adolescent girls
M. L. Robinson, K. Winters-Stone, K. Gabel, D. Dolny
Development of a nomogram for individualizing hip fracture risk in men and women
N. D. Nguyen, S. A. Frost, J. R. Center, J. A. Eisman, T. V. Nguyen
Correlation of plain radiographic indices of the hip with quantitative bone mineral density
A. P. Sah, T. S. Thornhill, M. S. LeBoff, J. Glowacki
A program with a dedicated coordinator improved chart documentation of osteoporosis after fragility fracture
S. E. Ward, J. J. Laughren, B. G. Escott, V. Elliot-Gibson, E. R. Bogoch, D. E. Beaton
Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?
K. A. Ward, J. E. Adams, T. J. Freemont, M. Z. Mughal
Estimates of fracture probability in Denmark
H. Johansson, A. Oden, E. McCloskey, J. Kanis
Estimates of fracture probability in Denmark: reply to Johansson et al
B. Abrahamsen